Sana Biotechnology, Inc.

SANA Healthcare Biotechnology

In the quarter to June 2026, EPS grew 43.6% and free cash flow fell 5.46%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

2.27 0.21 −8.47%
Market cap
$740.9M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

157.25 142.58 105.33 164.69
Total current assets
161.76 148.68 111.69 170.63
Property, Plant, Equpment (Net)
29.93 26.91 25.67 25.16
Goodwill and Intangible Assets (Total)
199.82 199.82 199.82 199.82
Long-term assets (Other)
3.22 3.17 0.56 0.55
Total non-current assets
273.67 268.21 261.90 260.89
Total Assets
435.43 416.89 373.59 431.52
Accounts Payable
1.86 1.67 2.12 1.36
Accrued Expenses
19.29 21.92 15.71 17.07
Other current liabilities
— 40.20 53.56 90.81
Total current liabilities
35.51 78.73 86.27 123.75
Non-current Liabilities (Other)
136.74 113.36 107.64 93.97
Total non-current liabilities
204.61 177.28 168.09 153.20
Total liabilities
240.12 256.01 254.35 276.95
Additional Paid In Capital
1,985.45 2,009.85 2,015.44 2,114.47
Common Stock (Net)
0.03 0.03 0.03 0.03
Retained Earnings
(1,790.19) (1,849.02) (1,896.23) (1,959.86)
Common Equity (Total)
195.31 160.88 119.24 154.57
Shareholders Equity (Total)
195.31 160.88 119.24 154.57
Shareholders Equity and Liabilities (Total)
435.43 416.89 373.59 431.52
Shares (Common)
262.26 266.73 269.82 299.31
Shareholders Equity (Tangible)
(4.51) (38.94) (80.58) (45.25)
Net Debt
(157.25) (142.58) (105.33) (164.68)

Fold the line items

In millions of $ except per-share values · columns are period end dates